European Companies Search Engine
Member of the Executive Board (4) · Change of legal form: BioNTech AG · Address · Proxy policy Hrb8 Mar 2019 German Trade Register Announcements, Germany
Overview
Text
HRB 48720: BioNTech SE,
Mainz, An der Goldgrube 12, 55131 Mainz
. European AG (SE). Articles of Association of November 30, 2018, amended in Section 4 (height and division of the share capital; different profit participation) by resolution of the Supervisory Board of January 30, 2019. Business address:
An der Goldgrube 12, 55131 Mainz
. General representation regulation: If only one member of the Board of Management is appointed, the latter alone represents the company. If several members of the Board of Management have been appointed, two members of the Executive Board shall represent jointly or one member of the Executive Board together with one authorized representative. Board of Directors: Marett, Sean, Halstenbek, *??.??.????; Prof. Dr. Sahin, Ugur, Mainz, *??.??.????; Dr. Türeci, Özlem, Mainz, *??.??.????, each authorized to represent in accordance with general representation regulations. Board of Directors: Dr. Poetting, Sierk, Munich, *??.??.????, authorized to represent individual parties with the power to enter into legal transactions on behalf of the company as a representative of a third party. Created by conversion by means of the change of form of BioNTechAG with its registered office in Mainz (Amtsgericht Mainz HRB 41865) in accordance with the conversion plan and the approval decision of the Annual General Meeting of November 30, 2018. By resolution of the Annual General Meeting of November 30, 2018, the Management Board is authorized to increase the share capital by up to EUR 5,360,794 in total, with the approval of the Supervisory Board, by a total of up to EUR 5,360,794 by August 15, 2023 against cash or non-cash deposits, without the approval of the Supervisory Board (authorized capital). The share capital of the company is conditionally increased by up to EUR 926,466.00 (Conditional capital 2017). The Conditional Capital is used exclusively for the granting of rights to Inh. stock options on the basis of the authorisation decision of the Annual General Meeting of the changed AG of August 18, 2017. A/S not registered: the creditors of the companies participating in the change in form shall be deemed to have declared their claim in writing in writing within six months of the date on which the registration of the change in form in the register of the registered office of those entities of which they are creditors is deemed to have been made known in accordance with Paragraph 19 (3) of the UmwG, provided that they cannot claim satisfaction. However, creditors are only entitled to this right if they demonstrate that the change in form jeopardises the fulfilment of their claim.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: BioNTech SE, Mainz, Germany.
The visualizations for "BioNTech SE - Member of the Executive Board (4) · Change of legal form: BioNTech AG · Address · Proxy policy"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
